IL6 and breast cancer: Recently, it was found that tumor exosome-derived miR-9 and miR-181a promote the formation of IL-6-high-expressing early myeloid-derived suppressor cells in breast cancer by suppressing key regulators, including SOCS3 and PIAS3, in the negative feedback circuit of the JAK/STAT signaling pathway (46).